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Objective. The present report aims to molecularly characterize 
seven clinical L. pneumophila (L. pn.) sg 1 isolated from noso-
comial acquired infections in Apulia region, using the European 
Working Group on Legionella Infections (EWGLI), sequence-
based typing (SBT) and amplified fragment length polymorphism 
(AFLP) protocols and to compare the identified sequence types 
(STs) with those available in the EWGLI database.
Methods. In the period, January 2000 - December 2012, 151 
cases (136 of community and 15 of nosocomial origin) of Legion-
naires’ disease were notified to the Regional Center for Epide-
miology. With regard to nosocomial cases, 8 were confirmed by 
the isolation of Legionella spp. from respiratory secretions. These 
clinical isolates were characterized by amplified fragment length 
polymorphism (AFLP) and sequence-based typing (SBT), using 
the EWGLI standardized protocol. 
Results. The clinical isolates belong to ST42, ST23 and ST1. 
The AFLP confirms the SBT results. Comparing the STs herein 
detected with those already in the EWGLI SBT database, the 3 
STs are frequent in other European countries.
Conclusions. The molecular analysis demonstrates that the 
3 STs are the most frequent in Italy and in Europe, supporting 
the hypothesis that some specific L. pn. sg 1 clones have gained 
widespread dissemination probably due to a common ecological 
niche. Further researches are required to investigate the potential 
changing incidence of STs and the fitness of emerging strains or 
clonal groups in environmental strains.
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Summary
Legionnaires’ disease (LD) is a form of pneumonia with 
no clinical features that clearly distinguish it from other 
types of pneumonia. Since the transmission occurs via 
inhalation of aerosols contaminated by Legionella spp., 
the frequent sources of infection are hot water systems, 
cooling towers and other water disseminators [1, 2]. At 
the same time, the problem is particularly important in 
hospital, where medical equipment can also be a po-
tential source of infection (endoscopes, devices for ar-
tificial respiration and oxygen therapy, dental devices, 
etc) [3-5].
Legionella pneumophila (L. pn.) is the aetiological agent 
of approximately 90% of Legionellosis cases, and L. pn. 
serogroup 1 (sg 1) is the predominant one  [6,  7]. The 
characterization of clinical isolates by molecular typing 
methods is essential for epidemiological investigations. 
The European Working Group on Legionella Infections 
(EWGLI) recently renamed European Study Group for 
Legionella Infections (ESGLI) has provided a descrip-
tion of a standardized protocol for the molecular identi-
fication of Legionella spp. firstly by amplified fragment 
length polymorphism (AFLP) [8] and more recently by 
sequence-based typing (SBT) [9]. In particular, SBT is a 
rapid and discriminatory method based on the sequence 
of seven loci (flaA, pilE, asd, mip, mompS, proA and 
neuA) of L. pn. Using the SBT protocol, the EWGLI has 
built up a database allowing the assignment of the seven 
ordered alleles represented as a Sequence Type (ST), or 
allelic profile. Successively, each study participant can 
submit his own data in order to increase information in 
the database and verify the circulation of L. pn. geno-
types in different geographic areas throughout the avail-
able Legionella isolates SBT map.
Apulia Region, with a land surface of 19,347 sq. km, 
is located in Southeastern Italy and its Regional Cent-
er for Epidemiology (OER) includes in its mission the 
surveillance of LD and the control of the environmental 
spread of Legionella spp. Information obtained from the 
environmental and clinical surveillance are maintained 
in a local computer database with real-time availability 
of all the information, allowing better programming of 
the necessary measures for prevention and control. At 
the same time, all environmental and clinical isolates of 
Legionella spp. are collected.
In the period, January 2000 - December 2012, 151 cases 
of LD were notified to the OER, according to the na-
tional compulsory reporting system: 136 of community 
and 15 of nosocomial origin. With regard to nosocomial 
LD cases, patient median age was 68.5 years (range 30-
98), and 60% were females. Eight patients (53.3%) were 
confirmed by two or more diagnostic methods; overall, 
80% tested positive for urinary antigen, 53.3% were 
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confirmed by the isolation of Legionella spp. from re-
spiratory secretions, 33.3% showed seroconversion and 
13.3% had one single positive antibody titer. All cases 
diagnosed by cultural examination acquired the infec-
tion in the largest Hospital of Apulia region which is 
composed up of 32 separate buildings with 60 bed-oper-
ating units, for a total bed capacity of 1,400. L. pn. sg 1 
and L. pn. sg 5 [10] were respectively isolated from sev-
en and one patients. Since 2000, in order to contain the 
spread of the disease, the water system of the hospital 
underwent to a periodical environmental monitoring for 
the detection of Legionella spp. in water samples; more-
over, additional environmental investigations are carried 
on when nosocomial cases are detected. According to 
the procedures described in the Italian Guidelines [11] 
treatment of disinfection (i.e., hyper-chlorination) is per-
formed.
The present report aims to molecularly characterize 
the seven clinical strain of L. pn. sg 1 isolated from 
nosocomial acquired infections in Apulia region, us-
ing the EWGLI SBT and AFLP protocols (version 
4.2 and 1.2, respectively, http://www.ewgli.org), and 
to compare the identified sequence types with those 
available in the EWGLI database. L.  pneumophila 
strain ATCC 33153 was included as control. The 
AFLP profiles were phylogenetically analyzed by the 
software GelCompare II (Applied Maths, Belgium) 
using as a cluster analysis, the Dice coefficient and 
the method “unweighted pair group method with av-
erages” (UPGMA). In agreement with Fry et al. [12], 
the isolates with homology greater than 90% have 
been considered homologous strains.
The results are summarized in Table  I. Our isolates 
can be classified into 3 distinct STs, by using the SBT 
method: five isolates (71.4% of all isolates) belong 
to the ST42, one to the ST23 (14.3%), and one to the 
ST1 (14.3%). The alphabetic designations (A, B and C) 
based on AFLP electrophoresis pattern confirm the SBT 
results.
The detected STs were submitted to the EWGLI SBT-
database and compared to those already in. According to 
the EWGLI database, the ST42 profile was found ubiq-
uitously across the Netherlands (n = 49), France (n = 29) 
and UK (n = 24). In Italy, a part from our 5 ST42, other 
seven ST42 strains were isolated: 5 of clinical origin (1 
nosocomial acquired) and two from environment.
With regard to ST1, the EWGLI database shows that its 
geographic distribution is mainly in France (n  =  225) 
and UK (n = 162). In Italy, a part from our unique ST1, 
26 isolates were identified: 16 were of clinical origin, of 
which 9 associated with nosocomial infections, and 10 
were environment strains. Finally, genotype ST23 was 
largely present in France (n = 364) followed by the Neth-
erlands (n = 31). In Italy, a part from our unique ST23, 
19 isolates were identified: 13 were clinical strains (all 
community acquired or travel associated cases) and 6 
environmental isolates. In addition, recently a cluster of 
travel-associated LD caused by ST23 in a small town 
located in North of Italy was documented by the Italian 
Institute of Health (ISS) [13].
Our molecular analysis carried out on L. pneumophila 
sg 1 clinical isolates associated with nosocomial infec-
tions, demonstrate perfectly overlapping results by both 
molecular methods, AFLP and SBT, as already shown by 
other Authors [14, 15]. In addition, these results confirm 
previous data on the distribution of STs in our country; 
as a matter of fact, the three STs identified are the most 
frequent in Italy. In particular according to the EWGLI 
records the ST1 is the most frequent, followed by ST23 
and ST42. These STs strains are frequently isolated also 
in Europe  [16,  17] and in other large geographic area 
such as Canada, China and Japan [7, 18, 19]. These find-
ings support the hypothesis that some specific L. pn. sg 1 
clones have gained widespread dissemination probably 
due to a common ecological niche. The Apulia region 
can be consider a well-integrated part of European eco-
system where the most common sequence types of L. pn. 
sg 1 appears to be not only ubiquitous and characterized 
by common epidemiological behaviors but also easily 
spreading.
Since Legionnaires’ disease occurs both in sporadic 
and epidemic forms, a rapid molecular identification of 
L. pn. is strongly suggested to control epidemics and to 
identify the source of infection.
In conclusions, further researches are required to inves-
tigate the potential changing incidence of STs and the 
fitness of emerging strains or clonal groups in environ-
mental strains too.
Tab. I. Clinical and molecular data of the 7 L. pn. sg 1 isolates recovered from nosocomial acquired infections.
Isolate identification Type of specimen, date of 
collection
SBT allele number (ST)
(flaA, pilE, asd, mip, mompS, proA, neuA)
AFLP pattern 
type
Leg1u Sputum, 11 February 2005 2,3,9,10,2,1,6 (ST23) A
Leg2u BA, 10 march 2004 4,7,11,3,11,12,9 (ST42) B
Leg3u BA, 6 October 2003 4,7,11,3,11,12,9 (ST42) B
Leg4u Sputum, 6 August 2002 4,7,11,3,11,12,9 (ST42) B
Leg5u BA, 11 September 2003 4,7,11,3,11,12,9 (ST42) B
Leg6u BA, 22 march 2003 4,7,11,3,11,12,9 (ST42) B
Leg7u Sputum, 15 march 2005 1,4,3,1,1,1,1 (ST1) C
BA: bronchoaspirate.
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